Sika AG (LON:0Z4C)

Verve Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	28,768	30,517	40,935	30,586	43,894	28,373
Market Cap Growth	-12.70%	-25.45%	33.84%	-30.32%	54.71%	41.24%
Enterprise Value	34,080	35,638	47,864	33,101	46,351	31,497
Last Close Price	181.61	187.18	247.91	191.80	293.41	191.07
PE Ratio	25.62	27.80	41.34	29.31	51.71	41.57
PS Ratio	2.70	2.94	3.91	3.25	5.86	4.35
PB Ratio	5.07	4.91	7.40	6.86	12.33	10.42
P/TBV Ratio	-	-	-	46.23	3897.95	-
P/FCF Ratio	26.36	24.52	30.13	39.54	59.75	27.35
P/OCF Ratio	20.27	19.86	25.61	30.98	50.92	24.96
EV/Sales Ratio	3.15	3.44	4.57	3.52	6.18	4.83
EV/EBITDA Ratio	16.31	18.91	24.29	20.74	34.30	27.24
EV/EBIT Ratio	21.43	23.44	29.37	24.73	40.96	33.78
EV/FCF Ratio	31.23	28.64	35.23	42.79	63.10	30.36
Debt / Equity Ratio	1.00	0.82	0.99	0.79	0.85	1.27
Debt / EBITDA Ratio	2.78	2.55	2.64	2.11	2.13	2.82
Debt / FCF Ratio	5.23	4.08	4.03	4.56	4.11	3.33
Asset Turnover	0.74	0.76	0.85	0.95	0.90	0.80
Inventory Turnover	3.82	4.13	4.25	4.48	4.52	4.24
Quick Ratio	1.03	1.12	0.78	1.76	1.32	1.47
Current Ratio	1.66	1.77	1.23	2.46	1.99	1.99
Return on Equity (ROE)	19.43%	19.22%	19.50%	24.83%	27.29%	25.59%
Return on Assets (ROA)	6.75%	6.95%	8.29%	8.46%	8.52%	7.13%
Return on Capital (ROIC)	8.42%	8.76%	10.56%	10.95%	11.20%	9.37%
Return on Capital Employed (ROCE)	13.50%	12.90%	15.00%	16.10%	16.20%	14.10%
Earnings Yield	3.90%	3.60%	2.42%	3.41%	1.93%	2.41%
FCF Yield	3.79%	4.08%	3.32%	2.53%	1.67%	3.66%
Dividend Yield	1.60%	1.70%	1.24%	1.50%	0.80%	1.08%
Payout Ratio	23.61%	21.25%	46.36%	38.35%	33.83%	39.54%
Buyback Yield / Dilution	0.49%	0.00%	-0.02%	-0.13%	-0.15%	-0.83%
Total Shareholder Return	2.09%	1.70%	1.22%	1.37%	0.65%	0.25%

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.